John C. Martin - Gilead
Total Compensation: $10.8 million
Details: Martin received roughly $1 million in salary, $1.6 million in bonuses and $3,800 in "other" compensation. Most of Martin's slary came from stock and option awards valued at about $10.1 million. Overall, Martin's compensation fell 6.8 percent from 2006.
Gilead News:
FDA approves Letairis [1]
Gilead touts Phase III Hep B results [2]
Links:
[1] http://www.fiercebiotech.com/story/gilead-shares-surge-on-letairis-approval/2007-06-18
[2] http://www.fiercebiotech.com/story/gilead-touts-phase-iii-hep-b-results/2007-06-25
[3] http://www.fiercebiotech.com/special-reports/genzyme-ceo-henri-termeer-ceo-pay-report
[4] http://www.fiercebiotech.com/special-reports/ceo-pay-who-makes-what-big-biotech
[5] http://www.fiercebiotech.com/special-reports/biogen-idec-ceo-james-mullen-ceo-pay-report